Orthocell Ltd (ASX:OCC) has received notification from the Australian Government Department of Health that CelGro® Dental has been included on the Australian Prostheses List.
Inclusion on the prostheses list enables dental practitioners to receive reimbursement from private insurers for use of CelGro® Dental in approved dental bone and soft tissue repair procedures, reducing costs to the patient.
The development positions the company favourably on its pathway to secure distribution partners.
“Australian access to premium product”
Orthocell managing director Paul Anderson said: “Inclusion of CelGro® Dental on the Prostheses List is the culmination of translational research and a regulatory program to bring this product to the Australian market.
“I am delighted that patients now have access to a premium dental membrane product designed, manufactured and reimbursed in Australia.”
Prostheses List
The Prostheses List defines the minimum value of benefit private insurers pay for CelGro® Dental used in approved dental bone and soft tissue repair procedures.
Receiving approval to be included on the Prostheses List follows the recent US and Australian market approvals for CelGro® collagen medical device, for introduction into the global dental bone and tissue regeneration markets, estimated at US$1 billion per annum.
Based on surgeon feedback and clinical data, the company believes CelGro® Dental (recently renamed Striate+TM) has distinct advantages over other similar products and may assist surgeons to deliver improved patient outcomes through superior handling characteristics, tissue integration qualities and improved bone healing.
Secure distribution partners
This reimbursement will assist the company in pursuing negotiations with multi-national dental companies and national dealers for marketing and distribution rights, with Orthocell to retain manufacturing of the finished product.
With the US, EU and Australian market approval achieved and key opinion leaders (KOLs) actively engaging with the program, Orthocell is well-positioned to secure distribution partners and establish Striate+TM (previously branded as CelGro Dental) as the premium dental collagen membrane.